Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib vs Bevacizumab with FOLFOX in Metastatic Colorectal Cancer
NCT00609622Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Apr 2008
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of sunitinib in metastatic colorectal cancer (mCRC), sponsored by Pfizer. Started Apr 2008; status: terminated.
02
Drugs
sunitinib
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00609622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00609622.